Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × lenvatinib × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 36 Cholangiocarcinoma 12 Carcinoma, Renal Cell 9 Liver Neoplasms 5 Stomach Neoplasms 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Liver Diseases 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Breast Neoplasms 2 Biliary Tract Neoplasms Immunotherapy 2 Advanced Solid Tumor 2 von Hippel-Lindau Disease 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Pancreatic Neoplasms 1

Interventions

pembrolizumab 51 Carboplatin 46 Magnetic Resonance Spectroscopy 40 Specimen Handling 38 Pemetrexed 36 Cisplatin 27 Blood Specimen Collection 25 durvalumab 17 Paclitaxel 17 osimertinib 15 Radiosurgery 15 Bevacizumab 15 Radiotherapy 14 Nivolumab 14 Gemcitabine 14 atezolizumab 13 Biopsy 13 Drug Therapy 11 Docetaxel 11 130-nm albumin-bound paclitaxel 11 Immunoglobulin G 10 X-Rays 9 Taxes 9 Standard of Care 9 Practice Guidelines as Topic 9 Etoposide 9 Disulfides 9 tislelizumab 8 Educational Status 8 Cetuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384015 2025-04-10

PEERS

Fundación GECP

Phase 2 Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡